Study Stopped
Halted prematurely
Immediate Intra Uterine Isemination (IUI) Versus Expectant Management in Postoperative Endometriosis Patients
Is Postoperative IUI Better Than Expectant Management in Infertile Endometriosis Patients With Good Prognosis Based on EFI Score?
1 other identifier
interventional
24
1 country
1
Brief Summary
Is postoperative IUI better than expectant management in infertile endometriosis patients with good prognosis based on their EFI score? (A single centre randomised controlled trial).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2014
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2014
CompletedFirst Submitted
Initial submission to the registry
March 23, 2015
CompletedFirst Posted
Study publicly available on registry
December 21, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
January 26, 2018
CompletedJuly 3, 2024
July 1, 2024
3.3 years
March 23, 2015
July 2, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
cumulative clinical pregnancy rate
participants will be followed for the duration of 7 menstrual cycles and in case of pregnancy, they will be followed until the pregnancy outcome is known, implying an average time frame of 1.5 year
Study Arms (2)
expectant
NO INTERVENTION7 menstrual cycles of expectant management
postop IUI
EXPERIMENTAL4 IUI cycles within 7 menstrual cycles
Interventions
Eligibility Criteria
You may qualify if:
- recent (\<6months) complete laparoscopic endometriosis resection
- endometriosis fertility index (EFI) at least 7/10
- Regular menstrual cycles (min 24days - max 38days) with proven ovulation
- At least one functional tube at surgery, normal uterus
- Sperm sample of partner: normal or mild male factor
You may not qualify if:
- frozen (donor or partner) sperm
- clinical and/or imaging evidence of endometriosis recurrence/persistence at randomization
- FSH \> 20 IU/L
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UZ Leuven
Leuven, 3000, Belgium
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Thomas D'Hooghe, MD, PhD
UZ Leuven
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 23, 2015
First Posted
December 21, 2015
Study Start
February 1, 2014
Primary Completion
June 1, 2017
Study Completion
January 26, 2018
Last Updated
July 3, 2024
Record last verified: 2024-07